🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: * Melanoma antigen recognized by T-cells (MART-1) and gp100 ar...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2008-12
Trial ID
NCT00923195
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Surgery Branch
Start Date
2001-02
Trial ID
NCT00020475
Treatments Being Tested
This randomized phase II trial is studying how well giving vaccine therapy ...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2011-02
Trial ID
NCT01307618
Lung cancer is the worldwide leading cause of cancer death. In France, with...
Status
Completed
Location
Institut Gustave Roussy
Start Date
2010-05-19
Trial ID
NCT01159288
Treatments Being Tested
The purpose of this study is to determine whether vaccination with melanoma...
Status
Completed
Location
Oncology Department, Lausanne University Hospital (CHUV) and University of Lausanne
Start Date
2004-02
Trial ID
NCT00112242
RATIONALE: Vaccines made from melanoma cells may make the body build an imm...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center and Hospital
Start Date
1999-06
Trial ID
NCT00006113
RATIONALE: Vaccines made by inserting a laboratory-treated gene into a pers...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2002-03
Trial ID
NCT00039325
Treatments Being Tested
RATIONALE: Vaccines made from a person's white blood cells combined with me...
Status
Unknown
Location
Dana-Farber Cancer Institute
Start Date
1999-03
Trial ID
NCT00004025
Treatments Being Tested
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Start Date
2004-05-31
Trial ID
NCT00084656
Treatments Being Tested
RATIONALE: Cytotoxic T lymphocytes (CTL) are cells of the immune system tha...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-08
Trial ID
NCT00512889